COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,384 Articles (22,816 medRxiv, 8,568 bioRxiv)

Most recent first Previous |  Page 1812: Articles 18111-18120  | Next

The efficacy and safety of Favipiravir in treatment of COVID-19: A systematic review and meta-analysis of clinical trials
Hassanpour, S., Arab-Zozani, M., Amani, B., Heidarzad, F., Fathalipour, M., Martinez-de-Hoyo, R.
10.1101/2021.02.14.21251693 — Posted: 2021-02-17
Use of Convalescent Plasma Therapy among Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Single-Center Experience
Mesina, F. Z., Mangahas, C. G., Gatchalian, E. M., Ramos, M. S. A., Torres, R. P.
10.1101/2021.02.16.21251824 — Posted: 2021-02-17
Impacts of COVID-19 on long-term health and health care use
Skyrud, K. D., Telle, K. E., Magnusson, K.
10.1101/2021.02.16.21251807 — Posted: 2021-02-17
Are we back to normal yet? The impact of the COVID-19 pandemic on mental health with a specific focus on schizotypal traits in the general population of Germany and the UK, comparing responses from April/May vs. September/October
Daimer, S., Mihatsch, L., Ronan, L., Murray, G. K., Knolle, F.
10.1101/2021.02.15.21251726 — Posted: 2021-02-17
Interrogating structural inequalities in COVID-19 Mortality in England and Wales
Griffith, G. J., Davey Smith, G., Manley, D., Howe, L. D., Owen, G.
10.1101/2021.02.15.21251771 — Posted: 2021-02-17
Epidemiological, Clinical Characteristics and Risk Factors for Severe Condition and ICU Admission of COVID-19 Patients of Early Stage in China: A review
Fu, Q., Wu, W., Liu, Y., Huang, H., Zhang, P., Li, X., Liu, Y., Zhang, L., Yang, H., Zhang, X., Zhang, Q., Huang, C.
10.1101/2021.02.15.21249676 — Posted: 2021-02-17
Moderators of changes in smoking, drinking, and quitting behaviour associated with the first Covid-19 lockdown in England
Jackson, S. E., Beard, E., Angus, C., Field, M., Brown, J.
10.1101/2021.02.15.21251766 — Posted: 2021-02-17
Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677
Hodcroft, E. B., Domman, D. B., Oguntuyo, K., Snyder, D. J., Diest, M. V., Densmore, K. H., Schwalm, K. C., Femling, J., Carroll, J. L., Scott, R. S., Whyte, M. M., Edwards, M. D., Hull, N. C., Kevil, C. G., Vanchiere, J. A., Lee, B., Dinwiddie, D. L., Cooper, V. S., Kamil, J. P.
10.1101/2021.02.12.21251658 — Posted: 2021-02-16 Discussion: Onsite
Learning Where to Look for COVID-19 Growth: Multivariate Analysis of COVID-19 Cases Over Time using Explainable Convolution-LSTM
Yudistira, N., Sumitro, S. B., Nahas, A. C., Riama, N. F.
10.1101/2021.02.13.21251683 — Posted: 2021-02-16
Recent SARS-CoV-2 seroconversion in a national, community-based prospective cohort of U.S. adults
Nash, D., Rane, M., Chang, M., Kulkarni, S., Zimba, R., You, W., Berry, A., Mirzayi, C., Kochhar, S., Maroko, A. R., Robertson, M., Westmoreland, D., Parcesepe, A., Waldron, L., Grov, C., for the CHASING COVID Cohort Study Team
10.1101/2021.02.12.21251659 — Posted: 2021-02-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).